This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Post-operative Pulmonary Complications
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.

Provided treatments

  • Device: Heated humified high-flow nasal cannula Oxygen
  • Other: Standard oxygen therapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03024112. The sponsor of the trial is University of Colorado, Denver and it is looking for 51 volunteers for the current phase.
Official trial title:
Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients